Teijin Pharma President To Become Group President
This article was originally published in PharmAsia News
Executive Summary
Teijin Pharma President Nario Oyagi is slated to be the new president of Teijin Group, and he is scheduled to be elected during the June 20 shareholders meeting. Oyagi joined the firm in 1971; he has since served as director for medical planning and general manager of medical business. Oyagi became president of Teijin Pharma in 2003. Discussing future visions for Teijin Pharma, Oyagi expects to expand worldwide into the home healthcare arena. Teijin Pharma has established an office in New York City, and it will actively promote business in America, Europe and Asia. (Click here for more-Japanese language